UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: Published Research

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Nature – In late 2021, the Omicron SARS-CoV-2 variant overtook the previously dominant Delta variant, but the extent to which this transition was driven by immune evasion or a change in the inherent transmissibility is currently unclear. We estimate SARS-CoV-2 transmission within Danish households during December 2021. Among 26,675 households (8,568 with the Omicron VOC), […]

Sep 23, 2022

Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19

NEJM – Cases of recurrence of clinical symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after completion of treatment with nirmatrelvir–ritonavir have been reported by researchers1 and in a Centers for Disease Control and Prevention Health Advisory.2 The frequency and clinical implications of potential recurrence of coronavirus disease 2019 (Covid-19) are unknown.

Sep 22, 2022

Post-Ebola Symptoms 7 Years after Infection: The natural history of Long Ebola

Clinical Infectious Diseases – Lingering symptoms have been reported by survivors of Ebola Virus Disease (EVD). There are few data describing the persistence and severity of these symptoms over time.

Sep 22, 2022

COVID deaths: more than 10 million children lost a parent or carer

Nature – Roughly 10.5 million children worldwide have a parent or carer who died from COVID-19, according to a modelling study1. The figure is a dramatic increase on earlier estimates. India, Indonesia and Egypt were the countries most affected; other regions throughout Africa and southeast Asia were also badly hit.

Sep 22, 2022

Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

The Lancet – Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults.

Sep 21, 2022

hOd LmX